Myofascial Pain Syndrome (MPS) Treatment Market is poised for substantial expansion, driven by the escalating global prevalence of chronic musculoskeletal disorders and significant advancements in non-invasive therapeutic techniques. The global myofascial pain syndrome (MPS) treatment market size was valued at USD 1.11 billion in 2024 and is projected to reach USD 2.23 billion by 2032,...